Sana Biotechnology Overview

  • Founded
  • 2018
Founded
  • Status
  • Public
  • Employees
  • 254
Employees
  • Stock Symbol
  • SANA
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $18.56
  • (As of Friday Closing)

Sana Biotechnology General Information

Description

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations.

Contact Information

Website
sana.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 188 East Blaine Street
  • Suite 400
  • Seattle, WA 98102
  • United States

Sana Biotechnology Timeline

201920202021
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sana Biotechnology Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.56 $18.36 $16.28 - $44.60 $3.48B 188M 464K -$3.46

Sana Biotechnology Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 6,822,363
Revenue 0 0 0
EBITDA (426,617) (280,131) (139,355)
Net Income (433,047) (285,305) (130,778)
Total Assets 1,304,466 730,296 415,192
Total Debt 70,259 71,909 47,701
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sana Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sana Biotechnology‘s full profile, request access.

Request a free trial

Sana Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Sana Biotechnology‘s full profile, request access.

Request a free trial

Sana Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to t
Drug Discovery
Seattle, WA
254 As of 2021
00.000
0.00 0000-00-00
00000000 00.000

0000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ull
0000000000000
Berkeley, CA
00 As of 0000
00000
00000000 00000

00000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud ex
0000000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sana Biotechnology Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Caribou Biosciences Venture Capital-Backed Berkeley, CA 00 00000 00000000 00000
00000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Sana Biotechnology Executive Team (14)

Name Title Board Seat Contact Info
Nate Hardy Chief Financial Officer
Edward Rebar Ph.D Chief Technology Officer, Technology & Senior Vice President
Robin Andrulevich Chief People Officer & Executive Vice President
Christian Hordo Executive Vice President & Executive
Sonja Schrepfer Executive & Senior Vice President
You’re viewing 5 of 14 executive team members. Get the full list »

Sana Biotechnology Board Members (19)

Name Representing Role Since
Alise Reicin MD Self Board Member 000 0000
Donald Payan MD Sana Biotechnology Board Member 000 0000
Douglas Cole MD Flagship Pioneering Board Member 000 0000
Geoffrey von Maltzahn Ph.D Self Board Member 000 0000
Hans Bishop Sana Biotechnology Co-Founder & Chairman 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Sana Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sana Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sana Biotechnology‘s full profile, request access.

Request a free trial

Sana Biotechnology Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 30-Oct-2020 000000000000000000 Discovery Tools (Healthcare)
0000000000 12-Nov-2019 000000000000000000 000 Biotechnology
000000 00000000000 11-Jun-2019 00000 00000 00 Discovery Tools (Healthcare)
Cobalt Biomedicine 01-Feb-2019 Merger/Acquisition 00000 Drug Delivery 00000 0000 00
To view Sana Biotechnology’s complete investments and acquisitions history, request access »